ATE441426T1 - Verwendung von angiotensinogen und deren analogen zur herstellung eines antiangiogenischen medikamentes - Google Patents

Verwendung von angiotensinogen und deren analogen zur herstellung eines antiangiogenischen medikamentes

Info

Publication number
ATE441426T1
ATE441426T1 AT02742921T AT02742921T ATE441426T1 AT E441426 T1 ATE441426 T1 AT E441426T1 AT 02742921 T AT02742921 T AT 02742921T AT 02742921 T AT02742921 T AT 02742921T AT E441426 T1 ATE441426 T1 AT E441426T1
Authority
AT
Austria
Prior art keywords
angiogenesis
expression vector
present
angiotensinogen
antiangiogenic
Prior art date
Application number
AT02742921T
Other languages
English (en)
Inventor
Jerome Celerier
Amauri Cruz
Noel Lamande
Jean-Marie Gasc
Pierre Corvol
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE441426T1 publication Critical patent/ATE441426T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02742921T 2001-04-26 2002-04-25 Verwendung von angiotensinogen und deren analogen zur herstellung eines antiangiogenischen medikamentes ATE441426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01401077A EP1252894A1 (de) 2001-04-26 2001-04-26 Verwendung von Angiotensinogen und deren Analogen zur Herstellung eines antiangiogenischen Medikamentes
PCT/EP2002/004666 WO2002087607A1 (en) 2001-04-26 2002-04-25 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE441426T1 true ATE441426T1 (de) 2009-09-15

Family

ID=8182703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02742921T ATE441426T1 (de) 2001-04-26 2002-04-25 Verwendung von angiotensinogen und deren analogen zur herstellung eines antiangiogenischen medikamentes

Country Status (7)

Country Link
US (2) US20040176286A1 (de)
EP (2) EP1252894A1 (de)
JP (1) JP2004526794A (de)
AT (1) ATE441426T1 (de)
CA (1) CA2445298A1 (de)
DE (1) DE60233564D1 (de)
WO (1) WO2002087607A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03277294A (ja) * 1990-03-28 1991-12-09 Saitetsuku Res:Kk 組換え型ヒトアンジオテンシノーゲンの製造方法
WO1997028684A1 (fr) * 1996-02-07 1997-08-14 Fujisawa Pharmaceutical Co., Ltd. Rat transgenique hypertendu
WO1998033813A2 (en) * 1997-02-04 1998-08-06 University Of Southern California Method for accelerating healing of thermal injuries
US6762167B1 (en) * 1998-05-11 2004-07-13 University Of Southern California Methods for treating a patient undergoing chemotherapy
AU5016200A (en) * 1999-05-21 2000-12-12 Myriad Genetics, Inc. Diabetes gene
AU2002220265A1 (en) * 2000-11-03 2002-05-15 University Of Vermont And State Agricultural College Compositions for inhibiting grb7

Also Published As

Publication number Publication date
CA2445298A1 (en) 2002-11-07
WO2002087607A1 (en) 2002-11-07
EP1392349B1 (de) 2009-09-02
EP1252894A1 (de) 2002-10-30
US20040176286A1 (en) 2004-09-09
US20080221036A1 (en) 2008-09-11
EP1392349A1 (de) 2004-03-03
JP2004526794A (ja) 2004-09-02
DE60233564D1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
NO941906D0 (no) Arylsubstituerte heterocykler
DE69415690T2 (de) (e)-20(22)-dehydrovitamin-d-verbindungen
CY1111594T1 (el) Μεθοδοι για τη θεραπευτικη αντιμετωπιση της ψυχωσης και της σχιζοφρενειας με βαση πολυμορφισμους στο γονιδιο του cntf
ATE534630T1 (de) Sulfonamidderivate und deren verwendung zur modulation von metalloproteinasen
SE0200356D0 (sv) Novel use
MX2007008997A (es) Anilidas de acido pirazolcarboxilico, un procedimiento para su obtencion y productos que contienen las mismas para combatir hongos nocivos.
WO2003051833A3 (en) Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
DE69320975T2 (de) Verwendung von (-) Cetirizin zur Behandlung allergischer Rhinitis und und Asthma
EE200200441A (et) 2-arüülpropioonhappe amiidide R-enantiomeerid, nende valmistamismeetod, farmatseutiline kompositsioon ja 2-arüülpropioonhapete R-enantiomeerid
DE69903865T2 (de) Wasserfreies Carbonylierungsverfahren zur Herstellung von Essigsäure
ATE309369T1 (de) Heterologe herstellung von polyketiden
ATE480235T1 (de) Verwendung von pramipexol zur behandlung von amyotrophischer lateralsklerose
ATE328965T1 (de) Azoverbindungen sowie verfahren zur herstellung derselben
ATE292633T1 (de) Substituierte piperazinderivate und ihre verwendung als fettsaüreoxidationsinhibitoren
BR0317857A (pt) Tratamento de anorexia nervosa (an) e bulimia
DE602004005502D1 (de) Comt-inhibitoren
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
PT1319064E (pt) Polipéptidos de gsk3
ATE441426T1 (de) Verwendung von angiotensinogen und deren analogen zur herstellung eines antiangiogenischen medikamentes
ATE431735T1 (de) Fusionierte cycloalkyl amid- und carbonsäure- derivate und deren therapeutische verwendung zur behandlung von u.a. epilepsie
ATE362359T1 (de) Amoxicillintrihydrat
MA27745A1 (fr) Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci.
DE69324066D1 (de) 4-Phenylcarbamoyl-3-isoxazolecarbonsäure-Derivate mit entzündungshemmender Aktivität
DE69415391T2 (de) Chinazolinonderivate
ATE206922T1 (de) Verwendung von amlexanox zur herstellung eines arzneimittels zur behandlung von aphtösen ulcera

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties